Does Ozempic Stop Working over Time Why Weight Loss Can Plateau

Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs

Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading.

CNBC - Feb. 24

Federal judge stops compounded copies of Eli Lilly weight loss, diabetes drugs

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision filed ...

The Hill - 4h

Why Walmart’s warning may have more to do with weight-loss drugs than tariffs

Walmart’s stock fell Thursday as quarterly earnings were expected to decline for the first time in three years, with strength in groceries and GLP-1 drug sales continuing to pressure margins.

MarketWatch - Feb. 21

Why Traditional Annual Planning Doesn’t Work, and What Does

The first 90 days are crucial to regroup and get the annual plan off the ground.

Inc. - Feb. 20

The Ozempic Shortage Is Over—for Now

The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs.

Inc. - Feb. 21

The Ozempic Shortage Is Over

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

Wired - Feb. 21

Why Guardiola's tactics stopped working amid rise of rapid football

BBC Sport analyses why Pep Guardiola's possession-focused tactics have stopped working amid the rise in rapid, direct football.

BBC News - Feb. 22

Drug compounders sue over weight loss drugs' removal from FDA shortage list

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug ...

The Hill - Feb. 25

Hims & Hers shares plunge 22% on concerns over weight loss business, margins

Hims & Hers on Monday released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its weight loss business.

CNBC - Feb. 25

There’s a price war over weight-loss drugs as Wegovy cuts costs for monthly subscribers

Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.

MarketWatch - 1d

Can Alternative for Germany be stopped?

The far-right party has made gains without seeking to moderate — rattling Europe and its largest democracy

Financial Times - 4d

Novo’s Weight Loss Drugs Removed from FDA Shortage List

The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list.

Inc. - Feb. 22

Healthy Returns: AbbVie is the newest potential weight loss drug market player

AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra's obesity drug. AI takes center stage at HIMSS conference gets underway in Vegas.

CNBC - 2d

From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

CNBC - Feb. 20

We know so little about taking weight-loss drugs without prescription – is it really worth it? | Devi Sridhar

Studies show that they’re effective for overweight people, but if you’re healthy, there are less risky ways to lose weight. When I’ve been in the gym over the past few months, one of the things ...

The Guardian - Feb. 25

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.

CNBC - Feb. 25

Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up

The drug company is calling on insurers and federal programs to cover obesity as a chronic disease.

MarketWatch - Feb. 26

Amgen starts two critical late-stage trials for weight loss drug MariTide

MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli Lilly.

CNBC - 1d

Why does a big elk sound so puny?

In this animated video essay, "Sunday Morning" contributor Robert Krulwich and animator Nate Milton go inside one of Nature's mysteries, to examine why an adult male elk, weighing around half a ...

CBS News - Feb. 23

Why Does Game Pass Remove Games?

Launched in 2017, Xbox Game Pass is something of a paradigm shift in the world of video games. For a monthly fee, members get access to a collection of games--including new releases from ...

GameSpot - 1d

In China you can get Ozempic and Wegovy within the hour for just $100 a month

Delivery apps are allowing Chinese citizens to get their hands on the popular weight-loss and diabetes drugs at the touch of a button.

MarketWatch - Feb. 25

Christianity in US stops decline after years of losses: Pew

The decline in the number of Americans who identify as Christian appears to be slowing down after years of losses, according to a Pew Research Center survey published Wednesday. The expansive ...

The Hill - Feb. 26

Why has PKK leader called on group to dissolve – and why does it matter?

Abdullah Öcalan’s declaration paves way for end to 40-year conflict between militant Kurdish groups and Turkish state. Jailed Kurdish leader calls for PKK to disarm The jailed leader of the ...

The Guardian - Feb. 27

Can Nvidia earnings rally the stock market and stop the bleeding in tech?

Highflying “Magnificent Seven” tech stock are in correction territory. Investors are watching Nvidia’s results to assess tech exposure.

MarketWatch - Feb. 26

What Trump says Canada, Mexico can do to stop tariff threat

Just two days after imposing 25% tariffs on imports from Canada and Mexico, President Trump is hitting the pause button. The president signed a series of executive orders on Thursday, granting ...

CBS News - 2h

$2 bills: Why does the US still print the rarely-used currency?

You may have never even held a $2 bill in your hand — so why do we still have it?

The Hill - 5d

Why Starmer is visiting Trump after Macron's stop at the White House

British Prime Minister Keir Starmer is in Washington, D.C., for a meeting with President Trump as European nations seek security guarantees for Ukraine in the peace talks with Russia. CBS News ...

CBS News - Feb. 27

‘Time is running out’: Lawmakers scramble for a deal to stop a shutdown

Short of a major breakthrough in the coming days, Congress is staring down the barrel of yet another crisis over government funding.

Politico - Feb. 21

Why ice loss in the Arctic is threatening polar bear populations

After a summer of fasting on land, the bears need to get back to their frozen home to hunt seals and bulk up. But their migration ritual is changing.

CBS News - Feb. 20

Loss to 76ers provides graphic proof why Warriors paid Butler

If you wonder why the Golden State Warriors were desperate enough to offer a two-year, $121 million contract extension to Jimmy Butler, you now have the answer.

Yahoo Sports - 5d

Why Demi Moore’s Oscar Loss to Mikey Madison Stings for Some Fans

Moore had been considered a favorite for her strong performance in “The Substance,” but Madison won for “Anora.”

The New York Times - 2d

Alarms raised over legitimacy of Fyre festival 2: ‘An event that does not exist’

Tourism and local officials in Mexico deny any knowledge of proposed follow-up to disastrous 2017 event. When tickets to the second Fyre festival went on sale this week , there was just one ...

The Guardian - Feb. 27

Medical training’s AI leap: How agentic RAG, open-weight LLMs and real-time case insights are shaping a new generation of doctors at NYU Langone

NYU Langone has built an LLM research companion and medical advisor, and is pioneering what it calls AI-driven “precision medical education."

VentureBeat - Feb. 20

Does Ozempic Stop Working over Time Why Weight Loss Can Plateau

Topics